Institut Jules Bordet
Belgium's only hospital devoted entirely to cancer, birthplace of the Breast International Group and a world centre for breast cancer trials.
Overview
The Institut Jules Bordet opened in 1939, named after the Nobel laureate immunologist Jules Bordet, and moved to a new building beside Erasme Hospital in Anderlecht in 2021 as part of the Hôpital Universitaire de Bruxelles. It is OECI-accredited as a comprehensive cancer centre. Martine Piccart co-founded the Breast International Group here and led the HERA trial of adjuvant trastuzumab; Christos Sotiriou's laboratory developed gene expression signatures for breast cancer and Michail Ignatiadis leads circulating tumour DNA studies, while Ahmad Awada's early-phase unit tests new agents. Bordet is also strong in haematology, nuclear medicine and surgical oncology, and Brussels hosts both BIG and EORTC headquarters.
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-22.
Matched to Institut Jules Bordet, including child institutions. 466 works · 8,781 citations · 74% open access · 16% clinical trials · 3% reviews.
- Evandro de Azambuja69 works
- Martine J Piccart50 works
- Francesco Sclafani39 works
- Christos P. Sotiriou35 works
- Nuria Kotecki30 works
- Elisa Agostinetto30 works
- Matteo Lambertini30 works
- Mariano Suppa29 works
- Denis Larsimont27 works
- Alain Hendlisz27 works
- Breast International Group
- Breast cancer genomics and ctDNA
- Early-phase trials
- Haematology
- Nuclear medicine
Similar pages
not linked directly; found by shared links- CompanyMerck & Co. (MSD)